AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

← Trials
🧪

Results of the Use of Two Stentrievers Simultaneosly Compared With One as a Primary Treatment in Acute Ischemic Stroke

RecruitingNAAges 18 Years - anyAllFundación EPIC
💬

In plain words

What the trial is, and whether it could suit you

Several studies have demonstrated that simultaneous treatment with two stentrievers (STs) as rescue treatment is very effective, with high recanalization rates even in this group of patients where other revascularization techniques have failed. There has been no observed increase in hemorrhagic complications. Recently, a prospective study has been published where treatment with two ST has been shown to be effective and safe if used as a first-choice treatment (not as rescue) with a successful recanalization rate (eTICI 2c/3) after the first pass of 69%. These results have been reinforced after the publication of a randomized study that confirms, in vitro, the superiority of using two ST over one.

Sign in to get the eligibility rules as simple questions to take to your doctor.

📋 Eligibility rules (as published)
Inclusion Criteria: * A new disabling focal neurological deficit compatible with acute cerebral ischemia. * Any age. Informed consent obtained from the patient or representative. * NIHSS score ≥ 6. * Pre-existing functional clinical status less than or equal to 2 according to the mRS clinical scale. * Maximum time of 24 hours from symptom onset to arterial puncture. • TICI 0-1 in the diagnosed TICA (terminal internal carotid artery) , MCA (middle cerebral artery), and BA( basilar artery confirmed by angioCT and angiography). * ASPECTs score on baseline CT greater than or equal to 6. * In cases where it is indicated, prior intravenous fibrinolysis will be administered according to the protocols of each center. Exclusion Criteria: * Those described in the usual protocols for mechanical thrombectomy of each hospital. * Pre-existing functional clinical status greater than 2 according to the mRS clinical scale * Patients with tandem lesions of dissection or arteriosclerotic origin located in the extracranial internal carotid artery. * Initiation of treatment with a different technique than the one described. * Inability to use a proximal balloon guide catheter. * Use of aspiration catheter. * Intracranial atherosclerotic plaque as the cause of occlusion. * Advanced or terminal disease with a life expectancy of less than 6 months. * Patient who is participating in another study that may affect this one. * ASPECTS score less than or equal to 6 on baseline CT. * Evidence of significant hemorrhage or mass effect with midline shift on baseline CT. * Patients with occlusions in multiple vascular territories. * Evidence of intracranial tumor (except for small meningiomas)
💊

What it tests

  • Double stentriever
  • Single stentriever
📍

Where

4 sites
Alfried Krupp Hospital Ruettenscheid
Essen, Germany
Hospital Universitario de Cruces
Barakaldo, Spain
Hospital Universitario Central de Asturias
Oviedo, Spain
Hospital Clínico Universitario de Valladolid
Valladolid, Spain
🤝 Taking part is your choice, and you can leave at any time. Only the trial team can confirm you are eligible — always decide together with your own doctor.
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy